Abstract
Toxicology is not a black art but a science which belongs to the general group of the pharmacological sciences. As such it must be analysed in terms of factors such as dose, route of administration, duration of exposure and individual (usually genetic) predisposition. The reason that toxicology, both in animals and in man, often does appear to be more of an art than a science is that prescribers, regulators and industrialists usually have to make their decisions on the basis of inadequate data. They do so in the name, often quite reasonably, of trying to minimize risk.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
(1978). Br. Heart J. 40, 1069–18
(1985). Br. Med. J. MRC trial of treatment of mild hypertension: principal result. Medical Research Council Working Party. 291, 97–97
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 MTP Press Limited
About this chapter
Cite this chapter
Dollery, C.T. (1987). The risk identified from clinical trials. In: Walker, S.R., Asscher, A.W. (eds) Medicines and Risk/Benefit Decisions. CMR Workshop Series. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-3221-0_6
Download citation
DOI: https://doi.org/10.1007/978-94-009-3221-0_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7946-4
Online ISBN: 978-94-009-3221-0
eBook Packages: Springer Book Archive